Chronic Kidney Disease, All-Cause Mortality and Cardiovascular Mortality Among Chinese Patients with Established Cardiovascular Disease
Jingang Yang(Shanghai Jiao Tong University), Dayi Hu(Beihang University), Yuejin Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Buaijiaer Hasimu(Xinjiang Medical University), Jue Li(Beijing Center for Disease Prevention and Control), Changlin Lu(Beijing Tongren Hospital)
Cited by 30
Related Papers
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
|New England Journal of Medicine|2013|603
Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance
|Stem Cell Research & Therapy|2019|157
Stroke prevention in atrial fibrillation—An Asian stroke perspective
|Heart Rhythm|2013|153
The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China
|American Heart Journal|2015|133
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol
|Journal of Thrombosis and Thrombolysis|2011|120